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Objectives 
Although hyperthermia treatment in oncology is widely known, few consider it an effective mainstream treatment 
due to its negative effects. However, a new method, electro-hyperthermia, is capable of harnessing the advantages 
of hyperthermia, while reducing the negative effects that render most traditional hyperthermia treatments 
ineffective. This review will introduce electro-hyperthermia and compare it with the more traditional hyperthermia 
treatments.  
Background — Hyperthermia 
The effects of traditional hyperthermia are well known. Some of the more important advantages and disadvantages 
are summarized in Table 1.  
Table 1.   Biological Effects of Traditional Hyperthermia [1] 
Positive Effects Negative Effects 
• Dividing cells (e.g. cancer cells), are more sensitive to heat,  
• Heat speeds up metabolism forcing tumors to use less 
efficient anaerobic pathways,  
• Low pH caused by anaerobic processes leads to acidosis,  
• Increased metabolism sensitizes the cells to chemo- and 
radiotherapy, 
• Hyperthermia primarily targets poorly oxygenated tissues 
thus complementing chemo- and radiotherapy. 
• Produces heat-shock proteins that protect 
the cells against damage,  
• May aid in the development of resistance 
against chemo- and/or radiotherapy,  
• May stimulate metastases formation,  
• Deep-heat delivery and focusing is a 
complex bioengineering problem.  
 
 
Most hyperthermia treatments heat an entire region, including the cells within the targeted tissue. The cells, 
however, produce stress-proteins (chaperons) in response to heat, in an attempt to adapt to the stress and prevent 
significant damage caused by the treatment. Malignant tissue can therefore develop resistance against heat, and 
can significantly reduce the effectiveness of hyperthermia. Furthermore, the stress proteins, induced by 
hyperthermia, can reduce the chemo- and radio-sensitivity of the cells; thus eliciting a negative effect [2]. 
Electro-Hyperthermia 
Electro-hyperthermia (EHY) has been developed to increase selectivity and reduce the disadvantages of traditional 
hyperthermia. EHY differs from other hyperthermia treatments by selectively heating the extracellular matrix 
(ECM) of the targeted tissue rather than the cells. The aim is to rapture the cell membrane, as well as to affect the 
voltage gated ionic channels, without creating high stresses inside the cell. By the time high stress levels reach the 
interior of the cell by slow heat diffusion, the damage to the cell is irreversible, causing cell death without the 
production of stress proteins. The first three disadvantages of classical hyperthermia are therefore eliminated. EHY 
also offers easy applicability to most organs (including brain, sexual organs, pancreas, etc.) and is more tolerable 
for patients than other treatments. Finally, it has improved coupling with other treatments (e.g. chemotherapy, 
radiotherapy, and surgery) and may block angiogenesis.  
Conclusions 
Based on this theory, several electro-hyperthermia devices have been developed to target a wide range of 
malignant sites with great success: a DC system for surface treatments, an AC device for intracavital treatments, 
and an RF-capacitive coupling system for deep-seated tumor treatments. The clinical results from these treatments 
show a drastic improvement over existing methods. 
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